Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid Training Vaccines 21.10.2022 ECRAID-Prime: Driving early treatment solutions in primary care Driving early treatment solutions in primary care 19.10.2022 ECRAID-Base: An exemplary collaboration in European clinical research Complex and multi-faceted, the project is split into 13 ‘work packages’, each one coordinated by a dedicated team. 13.10.2022 LAB-Net increases activities in POS-VAP LAB-Net plays a key role in the site selection process in most ECRAID-Base studies, including POS-VAP. 14.09.2022 POS-ARI-ER publication: A closer look at respiratory support failure in COVID-19 patients Study describes characteristics, outcomes and risk factors for failing non-invasive respiratory support in COVID-19 patients. 13.09.2022 Pandemic preparedness: Fighting antimicrobial resistance in the community Chris Butler on tackling AMR in the community setting 12.09.2022 Ecraid partners with Valneva for a COVID-19 booster vaccine trial Ecraid has begun its first clinical trial in partnership with specialty vaccine company Valneva. Load More
21.10.2022 ECRAID-Prime: Driving early treatment solutions in primary care Driving early treatment solutions in primary care
19.10.2022 ECRAID-Base: An exemplary collaboration in European clinical research Complex and multi-faceted, the project is split into 13 ‘work packages’, each one coordinated by a dedicated team.
13.10.2022 LAB-Net increases activities in POS-VAP LAB-Net plays a key role in the site selection process in most ECRAID-Base studies, including POS-VAP.
14.09.2022 POS-ARI-ER publication: A closer look at respiratory support failure in COVID-19 patients Study describes characteristics, outcomes and risk factors for failing non-invasive respiratory support in COVID-19 patients.
13.09.2022 Pandemic preparedness: Fighting antimicrobial resistance in the community Chris Butler on tackling AMR in the community setting
12.09.2022 Ecraid partners with Valneva for a COVID-19 booster vaccine trial Ecraid has begun its first clinical trial in partnership with specialty vaccine company Valneva.
